| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,554 |
4,315 |
$371K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,493 |
6,202 |
$360K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
602 |
578 |
$79K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
528 |
478 |
$44K |
| 87428 |
|
556 |
536 |
$29K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,525 |
1,455 |
$18K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
171 |
155 |
$17K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,057 |
528 |
$15K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
102 |
102 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
55 |
52 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
16 |
12 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
25 |
25 |
$736.81 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12 |
12 |
$411.62 |